Form 4: Medtronic Director Andrea Jo Goldsmith Reports Changes in Beneficial Ownership

Director Andrea Jo Goldsmith reports acquisition of Medtronic shares through restricted stock units and dividend reinvestment.

Summary

• On April 29, 2024, Andrea Jo Goldsmith, a director of Medtronic plc, acquired 2,165 ordinary shares through a restricted stock unit award at a price of $80.86.
• These restricted stock units vest on the one-year anniversary of the award date.
• Additionally, Goldsmith acquired 66 shares through dividend reinvestment since the last report.
• Following these transactions, Goldsmith beneficially owns 8,498 Medtronic ordinary shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions by a company director. The acquisition of shares could be seen as a slightly positive signal, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company director.

Key Dates